ZA200207891B - Starch sub-types and lipid metabolism. - Google Patents
Starch sub-types and lipid metabolism. Download PDFInfo
- Publication number
- ZA200207891B ZA200207891B ZA200207891A ZA200207891A ZA200207891B ZA 200207891 B ZA200207891 B ZA 200207891B ZA 200207891 A ZA200207891 A ZA 200207891A ZA 200207891 A ZA200207891 A ZA 200207891A ZA 200207891 B ZA200207891 B ZA 200207891B
- Authority
- ZA
- South Africa
- Prior art keywords
- individual
- fat
- resistant starch
- intake
- composition according
- Prior art date
Links
- 229920002472 Starch Polymers 0.000 title claims description 66
- 235000019698 starch Nutrition 0.000 title claims description 65
- 239000008107 starch Substances 0.000 title claims description 43
- 230000037356 lipid metabolism Effects 0.000 title description 3
- 229920000294 Resistant starch Polymers 0.000 claims abstract description 139
- 235000021254 resistant starch Nutrition 0.000 claims abstract description 139
- 238000000034 method Methods 0.000 claims abstract description 106
- 239000000203 mixture Substances 0.000 claims abstract description 94
- 235000021081 unsaturated fats Nutrition 0.000 claims abstract description 79
- 239000003925 fat Substances 0.000 claims abstract description 66
- 235000019197 fats Nutrition 0.000 claims abstract description 66
- 235000014633 carbohydrates Nutrition 0.000 claims abstract description 41
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 40
- 235000021003 saturated fats Nutrition 0.000 claims abstract description 40
- 235000021074 carbohydrate intake Nutrition 0.000 claims abstract description 25
- 230000004060 metabolic process Effects 0.000 claims abstract description 18
- 230000001105 regulatory effect Effects 0.000 claims abstract description 10
- 235000005911 diet Nutrition 0.000 claims description 94
- 230000037213 diet Effects 0.000 claims description 87
- 229920000856 Amylose Polymers 0.000 claims description 37
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 34
- 230000001965 increasing effect Effects 0.000 claims description 28
- 235000012054 meals Nutrition 0.000 claims description 27
- 230000003647 oxidation Effects 0.000 claims description 22
- 238000007254 oxidation reaction Methods 0.000 claims description 22
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 19
- 239000008103 glucose Substances 0.000 claims description 19
- 102000004877 Insulin Human genes 0.000 claims description 17
- 108090001061 Insulin Proteins 0.000 claims description 17
- 229940125396 insulin Drugs 0.000 claims description 17
- 102000016267 Leptin Human genes 0.000 claims description 15
- 108010092277 Leptin Proteins 0.000 claims description 15
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 claims description 15
- 229940039781 leptin Drugs 0.000 claims description 15
- 208000008589 Obesity Diseases 0.000 claims description 14
- 235000020824 obesity Nutrition 0.000 claims description 14
- 230000036186 satiety Effects 0.000 claims description 14
- 235000019627 satiety Nutrition 0.000 claims description 13
- 239000004615 ingredient Substances 0.000 claims description 12
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 230000009467 reduction Effects 0.000 claims description 11
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 11
- 230000000291 postprandial effect Effects 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 8
- 235000012631 food intake Nutrition 0.000 claims description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 7
- 239000011707 mineral Substances 0.000 claims description 7
- 235000010755 mineral Nutrition 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 6
- 235000013343 vitamin Nutrition 0.000 claims description 6
- 239000011782 vitamin Substances 0.000 claims description 6
- 229940088594 vitamin Drugs 0.000 claims description 6
- 229930003231 vitamin Natural products 0.000 claims description 6
- 230000002708 enhancing effect Effects 0.000 claims description 5
- 229920002261 Corn starch Polymers 0.000 claims description 4
- 235000019759 Maize starch Nutrition 0.000 claims description 4
- 238000009825 accumulation Methods 0.000 claims description 4
- 239000000470 constituent Substances 0.000 claims description 4
- 230000001276 controlling effect Effects 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000013355 food flavoring agent Nutrition 0.000 claims description 4
- 239000008187 granular material Substances 0.000 claims description 4
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 3
- 239000003792 electrolyte Substances 0.000 claims description 3
- 235000021084 monounsaturated fats Nutrition 0.000 claims description 3
- 235000021085 polyunsaturated fats Nutrition 0.000 claims description 3
- 239000011573 trace mineral Substances 0.000 claims description 3
- 235000013619 trace mineral Nutrition 0.000 claims description 3
- 235000020845 low-calorie diet Nutrition 0.000 claims 1
- 235000021180 meal component Nutrition 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 235000013305 food Nutrition 0.000 description 22
- 241000700159 Rattus Species 0.000 description 17
- 230000000694 effects Effects 0.000 description 12
- 230000004044 response Effects 0.000 description 12
- 229920000945 Amylopectin Polymers 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 150000002632 lipids Chemical class 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 240000008042 Zea mays Species 0.000 description 8
- 230000001154 acute effect Effects 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000037406 food intake Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 7
- 230000000378 dietary effect Effects 0.000 description 7
- 235000021588 free fatty acids Nutrition 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 6
- 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 6
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 6
- 210000003486 adipose tissue brown Anatomy 0.000 description 6
- 210000000593 adipose tissue white Anatomy 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 235000008429 bread Nutrition 0.000 description 6
- 210000003016 hypothalamus Anatomy 0.000 description 6
- 230000004132 lipogenesis Effects 0.000 description 6
- 235000009973 maize Nutrition 0.000 description 6
- 235000012459 muffins Nutrition 0.000 description 6
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 229920002527 Glycogen Polymers 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 210000002108 dorsomedial hypothalamic nucleus Anatomy 0.000 description 5
- 229940096919 glycogen Drugs 0.000 description 5
- 235000021374 legumes Nutrition 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 241000282412 Homo Species 0.000 description 4
- 240000005979 Hordeum vulgare Species 0.000 description 4
- 235000007340 Hordeum vulgare Nutrition 0.000 description 4
- 206010022489 Insulin Resistance Diseases 0.000 description 4
- 240000005561 Musa balbisiana Species 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 244000061456 Solanum tuberosum Species 0.000 description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000000446 fuel Substances 0.000 description 4
- 235000013310 margarine Nutrition 0.000 description 4
- 239000003264 margarine Substances 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000001537 neural effect Effects 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 244000188595 Brassica sinapistrum Species 0.000 description 3
- 241000218206 Ranunculus Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 241000209140 Triticum Species 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 210000000577 adipose tissue Anatomy 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000015496 breakfast cereal Nutrition 0.000 description 3
- 239000000306 component Substances 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 210000005228 liver tissue Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000002503 metabolic effect Effects 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 208000016261 weight loss Diseases 0.000 description 3
- 235000012794 white bread Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 description 2
- 235000006008 Brassica napus var napus Nutrition 0.000 description 2
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 description 2
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 2
- 206010033307 Overweight Diseases 0.000 description 2
- 240000003829 Sorghum propinquum Species 0.000 description 2
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 235000019486 Sunflower oil Nutrition 0.000 description 2
- 235000019714 Triticale Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008186 active pharmaceutical agent Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 2
- 235000021015 bananas Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- 235000019519 canola oil Nutrition 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000013367 dietary fats Nutrition 0.000 description 2
- 235000021004 dietary regimen Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 238000006266 etherification reaction Methods 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000005428 food component Substances 0.000 description 2
- 238000007446 glucose tolerance test Methods 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 230000004121 glycogenesis Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002267 hypothalamic effect Effects 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 210000002963 paraventricular hypothalamic nucleus Anatomy 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000002600 sunflower oil Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000021195 test diet Nutrition 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 210000000575 ventromedial hypothalamic nucleus Anatomy 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 241000228158 x Triticosecale Species 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 229920001685 Amylomaize Polymers 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 101001005200 Drosophila melanogaster Protein limb expression 1 homolog Proteins 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940025131 amylases Drugs 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 235000012970 cakes Nutrition 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000021045 dietary change Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000019007 dietary guidelines Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 235000021196 dietary intervention Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000019869 fractionated palm oil Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 102000005861 leptin receptors Human genes 0.000 description 1
- 108010019813 leptin receptors Proteins 0.000 description 1
- 235000021142 long-term diet Nutrition 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 230000003050 macronutrient Effects 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000002715 modification method Methods 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000006286 nutrient intake Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 235000015504 ready meals Nutrition 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 230000037078 sports performance Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 1
- 229960001052 streptozocin Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 210000002820 sympathetic nervous system Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000021076 total caloric intake Nutrition 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- -1 unsaturated fatty acid esters Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pediatric Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Edible Oils And Fats (AREA)
- Grain Derivatives (AREA)
- Jellies, Jams, And Syrups (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPQ6733A AUPQ673300A0 (en) | 2000-04-06 | 2000-04-06 | Starch sub-types and lipid metabolism |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200207891B true ZA200207891B (en) | 2004-01-26 |
Family
ID=3820828
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200207891A ZA200207891B (en) | 2000-04-06 | 2002-10-01 | Starch sub-types and lipid metabolism. |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20030045504A1 (ko) |
| EP (1) | EP1267642B1 (ko) |
| JP (2) | JP2003529616A (ko) |
| KR (1) | KR20020090229A (ko) |
| CN (1) | CN100435665C (ko) |
| AT (1) | ATE387861T1 (ko) |
| AU (1) | AUPQ673300A0 (ko) |
| BR (1) | BR0109960A (ko) |
| CA (1) | CA2405012A1 (ko) |
| CR (1) | CR6807A (ko) |
| DE (1) | DE60133093T2 (ko) |
| DK (1) | DK1267642T3 (ko) |
| ES (1) | ES2305063T3 (ko) |
| HK (1) | HK1052618A1 (ko) |
| MX (1) | MXPA02009879A (ko) |
| NO (1) | NO20024722L (ko) |
| NZ (1) | NZ521416A (ko) |
| PT (1) | PT1267642E (ko) |
| WO (1) | WO2001076394A1 (ko) |
| ZA (1) | ZA200207891B (ko) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60221234T2 (de) * | 2001-04-09 | 2008-05-21 | Danisco A/S | Verwendung von füllstoffe als sättigungsmittel |
| US7252836B2 (en) | 2003-01-13 | 2007-08-07 | Penwest, Ltd. | Food and feed compositions including resistant starch |
| RU2377303C2 (ru) | 2003-06-30 | 2009-12-27 | Коммонвелт Сайентифик Энд Индастриал Рисерч Организейшн | Пшеница с модифицированной активностью ветвящего фермента, а также полученные из нее крахмал и крахмалсодержащие продукты |
| GB0325942D0 (en) * | 2003-11-06 | 2003-12-10 | Glycologic Ltd | Compositions and uses thereof |
| US20060025381A1 (en) * | 2004-07-29 | 2006-02-02 | National Starch And Chemical Investment Holding Company | Use of a chemically modified starch product |
| US20060025382A1 (en) * | 2004-07-29 | 2006-02-02 | Ian Brown | Use of a crosslinked or inhibited starch product |
| US7189288B2 (en) * | 2004-10-08 | 2007-03-13 | Tate & Lyle Ingredients Americas, Inc. | Enzyme-resistant starch and method for its production |
| US7276126B2 (en) * | 2005-06-03 | 2007-10-02 | Tate And Lyle Ingredients Americas, Inc. | Production of enzyme-resistant starch by extrusion |
| US7674897B2 (en) * | 2005-09-09 | 2010-03-09 | Tate & Lyle Ingredients Americas, Inc. | Production of crystalline short chain amylose |
| US7608436B2 (en) * | 2006-01-25 | 2009-10-27 | Tate & Lyle Ingredients Americas, Inc. | Process for producing saccharide oligomers |
| US8057840B2 (en) * | 2006-01-25 | 2011-11-15 | Tate & Lyle Ingredients Americas Llc | Food products comprising a slowly digestible or digestion resistant carbohydrate composition |
| US8993039B2 (en) | 2006-01-25 | 2015-03-31 | Tate & Lyle Ingredients Americas Llc | Fiber-containing carbohydrate composition |
| JP2008259464A (ja) * | 2007-04-13 | 2008-10-30 | Matsutani Chem Ind Ltd | 腹持ち持続剤及び飲食品 |
| AR087158A1 (es) | 2011-06-20 | 2014-02-26 | Gen Biscuit | Masita en capas saludable |
| AU2014305623B2 (en) * | 2013-08-07 | 2019-01-24 | Mcpharma Biotech Inc. | Improvement of blood lipids, glucose tolerance and insulin sensitivity |
| US20190256614A1 (en) * | 2013-08-07 | 2019-08-22 | Mcpharma Biotech Inc. | Blood Lipids, Glucose Tolerance and Insulin Sensitivity |
| GB201801909D0 (en) * | 2018-02-06 | 2018-03-21 | New Food Innovation Ltd | Medium/low glycaemic index products and methods |
| US11540549B2 (en) | 2019-11-28 | 2023-01-03 | Tate & Lyle Solutions Usa Llc | High-fiber, low-sugar soluble dietary fibers, products including them and methods for using them |
| WO2024007072A1 (en) * | 2022-07-04 | 2024-01-11 | Mcpharma Biotech Inc. | Metabolomic improvements using resistant starch supplementation |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4345234A (en) * | 1980-12-15 | 1982-08-17 | Deere & Company | Multiple element thermal actuator |
| EP0506166A3 (en) * | 1991-03-25 | 1993-01-13 | Unilever N.V. | Ingestible material |
| JPH0549383A (ja) * | 1991-08-28 | 1993-03-02 | Ichinobe Seipan Kk | 焼き菓子類の製造方法 |
| US5268367A (en) * | 1991-12-30 | 1993-12-07 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Composition and method for lowering blood level of LDL-cholesterol |
| EP0562140A1 (en) * | 1992-03-25 | 1993-09-29 | Terumo Kabushiki Kaisha | Method of preparing a modified wheat flour |
| US5470839A (en) * | 1993-04-22 | 1995-11-28 | Clintec Nutrition Company | Enteral diet and method for providing nutrition to a diabetic |
| DE19503993A1 (de) * | 1995-02-08 | 1996-08-14 | Johann Friedrich Dr Med Desaga | Verwendung eines Produktes zur enteralen Versorgung mit Lebensmittelinhaltsstoffen oder Arzneimittelinhaltsstoffen |
| US5593503A (en) * | 1995-06-07 | 1997-01-14 | National Starch And Chemical Investment Holding Corporation | Process for producing amylase resistant granular starch |
| ES2123903T5 (es) * | 1995-08-04 | 2011-02-22 | N.V. Nutricia | Composición nutritiva conteniendo fibra. |
| MY115050A (en) * | 1995-10-16 | 2003-03-31 | Mead Johnson Nutrition Co | Diabetic nutritional product having controlled absorption of carbohydrate |
| US5849090A (en) * | 1996-03-27 | 1998-12-15 | Opta Food Ingredients, Inc. | Granular resistant starch and method of making |
| DK0843972T3 (da) * | 1996-11-20 | 2002-12-02 | Nutricia Nv | Næringsmiddelsammensætning, der indeholder fedtstoffer til behandling af stofskiftesygdomme |
| GB9625129D0 (en) * | 1996-12-03 | 1997-01-22 | Cerestar Holding Bv | Highly fermentable resistant starch |
| JPH10279487A (ja) * | 1997-04-01 | 1998-10-20 | Nippon Shokuhin Kako Co Ltd | 脂質代謝改善剤 |
| US5855946A (en) * | 1997-06-06 | 1999-01-05 | Kansas State University Research Foundation | Food grade starch resistant to α-amylase and method of preparing the same |
| JPH11209279A (ja) * | 1998-01-05 | 1999-08-03 | Natural Ltd As | 体重減少および肥満処置の方法 |
| DE19860375A1 (de) * | 1998-12-28 | 2000-07-06 | Aventis Res & Tech Gmbh & Co | Alpha Amylase-resistente Stärke zur Herstellung von Nahrungs- und Arzneimittel |
-
2000
- 2000-04-06 AU AUPQ6733A patent/AUPQ673300A0/en not_active Abandoned
-
2001
- 2001-04-06 US US10/009,023 patent/US20030045504A1/en not_active Abandoned
- 2001-04-06 CA CA002405012A patent/CA2405012A1/en not_active Abandoned
- 2001-04-06 KR KR1020027013433A patent/KR20020090229A/ko not_active Application Discontinuation
- 2001-04-06 DE DE60133093T patent/DE60133093T2/de not_active Expired - Lifetime
- 2001-04-06 DK DK01919008T patent/DK1267642T3/da active
- 2001-04-06 BR BR0109960-4A patent/BR0109960A/pt not_active IP Right Cessation
- 2001-04-06 NZ NZ521416A patent/NZ521416A/en unknown
- 2001-04-06 WO PCT/AU2001/000392 patent/WO2001076394A1/en active IP Right Grant
- 2001-04-06 EP EP01919008A patent/EP1267642B1/en not_active Expired - Lifetime
- 2001-04-06 AT AT01919008T patent/ATE387861T1/de not_active IP Right Cessation
- 2001-04-06 ES ES01919008T patent/ES2305063T3/es not_active Expired - Lifetime
- 2001-04-06 CN CNB018107478A patent/CN100435665C/zh not_active Expired - Lifetime
- 2001-04-06 PT PT01919008T patent/PT1267642E/pt unknown
- 2001-04-06 MX MXPA02009879A patent/MXPA02009879A/es not_active Application Discontinuation
- 2001-04-06 JP JP2001573922A patent/JP2003529616A/ja active Pending
-
2002
- 2002-10-01 ZA ZA200207891A patent/ZA200207891B/en unknown
- 2002-10-02 NO NO20024722A patent/NO20024722L/no not_active Application Discontinuation
- 2002-11-01 CR CR6807A patent/CR6807A/es not_active Application Discontinuation
-
2003
- 2003-06-26 HK HK03104598.5A patent/HK1052618A1/zh unknown
- 2003-07-15 US US10/619,794 patent/US20040058890A1/en not_active Abandoned
-
2012
- 2012-07-30 JP JP2012168848A patent/JP2013010762A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NO20024722D0 (no) | 2002-10-02 |
| ATE387861T1 (de) | 2008-03-15 |
| HK1052618A1 (zh) | 2003-09-26 |
| EP1267642A1 (en) | 2003-01-02 |
| DK1267642T3 (da) | 2008-06-30 |
| BR0109960A (pt) | 2003-02-11 |
| AUPQ673300A0 (en) | 2000-05-04 |
| PT1267642E (pt) | 2008-06-06 |
| JP2013010762A (ja) | 2013-01-17 |
| ES2305063T3 (es) | 2008-11-01 |
| DE60133093T2 (de) | 2009-04-02 |
| JP2003529616A (ja) | 2003-10-07 |
| EP1267642A4 (en) | 2005-08-17 |
| KR20020090229A (ko) | 2002-11-30 |
| DE60133093D1 (de) | 2008-04-17 |
| WO2001076394A1 (en) | 2001-10-18 |
| CN1433275A (zh) | 2003-07-30 |
| MXPA02009879A (es) | 2004-09-06 |
| NO20024722L (no) | 2002-11-29 |
| US20030045504A1 (en) | 2003-03-06 |
| CN100435665C (zh) | 2008-11-26 |
| NZ521416A (en) | 2004-11-26 |
| EP1267642B1 (en) | 2008-03-05 |
| CA2405012A1 (en) | 2001-10-18 |
| US20040058890A1 (en) | 2004-03-25 |
| CR6807A (es) | 2003-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jeukendrup et al. | Sport nutrition | |
| EP1267642B1 (en) | Composition comprising resistant starch and unsaturated fats | |
| CN101035594B (zh) | 用于糖尿病患者的食品 | |
| EP3135119B1 (en) | Beverage composition for weight gain suppression | |
| CN101912090B (zh) | 辅助降血脂青稞保健粥及其制备方法 | |
| US20040265360A1 (en) | Ingestible composition | |
| CN110663872A (zh) | 一种全营养代餐减肥食品、制备方法及食用方法 | |
| Thomas et al. | Eat for life: the food and nutrition board's guide to reducing your risk of chronic disease | |
| Chaturvedi et al. | Glycemic index of grain amaranth, wheat and rice in NIDDM subjects | |
| WO2005099483A1 (en) | Ingestible composition | |
| Toeller et al. | Nutrition in the etiology and management of type 2 diabetes | |
| US20100029581A1 (en) | Nutritional supplement | |
| Heaton | Food intake regulation and fiber | |
| TWI593359B (zh) | 西式飲食之營養補償方法 | |
| AU784805B2 (en) | Starch sub-types and lipid metabolism | |
| NZ535805A (en) | Starch sub-types and lipid metabolism | |
| Karst | The metabolic syndrome program: how to lose weight, beat heart disease, stop insulin resistance and more | |
| US20090311351A1 (en) | Composition containing a cereal milling product | |
| Akram et al. | Compositional profiling and bioefficacy studies of pulses-supplemented isocaloric designer biscuits for recently diagnosed diabetic individuals | |
| WO2023077394A1 (zh) | 一种调理血糖平衡的冲调即食粉 | |
| Dimosthenopoulos et al. | Principles of Healthy Nutrition | |
| Arguin et al. | Fruit and vegetables, energy balance and weight management. | |
| HOFFER | Calories, Protein, Lipids, Carbohydrates, and the Saccharine Diseases | |
| Dämon et al. | Ernährung und Diabetes mellitus: eine Übersicht zur derzeitigen Evidenzlage | |
| Skeaff | Plenary 1: Vitamin D; The Great Debate |